ICMR, India’s apex Health Research Facility, isolates COVID-19

New Delhi: Indian Council of Medical Research (ICMR), the apex health research body of India has successfully isolated the COVID-19 virus strain. The isolation is the first step towards expediting the development of drugs, vaccines and rapid diagnostic kits in the country.

The other countries that have isolated the virus are Japan, Thailand, United States of America and China. ICMR has been closely working with the Ministry of Health, and other departments to coordinate the effort to tackle COVID-19.

ICMR, which is also the testing agency for the virus, has expanded its network of labs equipped to test COVID-19 from 51 to 65. The secondary test for reconfirmation of the virus which was earlier conducted only in National Institute of Virology have also been expanded to 31 labs. These steps will enable India to expedite detection of the virus and will help in effective management.

Till date ICMR has tested more than 6500 samples of 5900 individuals, out of which 78 cases have been tested positive for the virus. ICMR is equipped to handle more volumes of samples if the need arises.

Prof (Dr) Balram Bhargava, Secretary, Department of Health Research & Director General, ICMR, said “People should not panic, but take precautionary measures. Strong systems and processes are in place to deal with COVID-19 and the Ministry is constantly monitoring the situation. We at ICMR have been constantly in a vigil mode and our laboratories have enough capacity to test. We will be issuing advisories and revising guidelines for testing as and when necessary.”

Related Posts

‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

Domestic Medical Device Leaders cry foul against move to do away with Policy Restrictions New Delhi:  The union government mandarins seem to be at it again, diametrically opposed to Prime…

Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India

Best in Class ‘Made in India’ Surgical Robot is proving Best Bet New Delhi: ‘Made in India’ best in class surgical robot SSiMantra is proving godsend for cancer patients in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward